Jeff Millard Email and Phone Number
Jeff Millard work email
- Valid
- Valid
- Valid
- Valid
- Valid
Jeff Millard personal email
- Valid
- Valid
- Valid
- Valid
Jeff Millard phone numbers
I have both academic and extensive industrial experience in chemistry and pharmaceutical sciences covering all aspects of CMC (chemistry, manufacturing, and controls). I've been a Research Assistant Professor at the University of Arizona since 2002 where I lectured for the pharmaceutical chemistry and physical pharmacy course for the Pharm D program. I've been involved in both start-up novel small molecule pharmaceutical companies as well as mid-sized and large public biopharmaceutical companies. I've been directly responsible for the research and IND authoring of more than 16 IND submissions (to both CDER and CBER), IMPDs, and many successful grant applications totaling over $40MM. My experience covers a range of R&D as well as business and partnering activities. I've been on due diligence teams for several partnerships and two acquisitions. I direct the CMC efforts from discovery and in/out-licensing through commercial launch activities. My API experience covers the lifecycle from synthetic route scouting and medicinal chemistry, process chemistry, crystal form, salt and polymorph selection, analytical chemistry development and validation, cGMP production and release of API, to QbD and PPQ. My drug product experience includes pre-formulation, QSPR, formulation, tech transfer and cGMP manufacturing of both solid oral dosages as well as sterile, complex parenterals (including nanomedicines, lipid nanoparticles, and liposomes), topicals, and inhalation products. I've been responsible for the scaling of numerous synthetic routes from milligram med-chem scales through validated cGMP commercial processes at hundreds of kilos per batch. I've taken two products from discovery through Phase 3 international pivotal studies and one of those through commercial launch. Specialties: CMC, regulatory filings, synthetic route selection and process chem dev, tech transfer, due diligence, solid state characterization, pre-formulation and formulation, ADMET/PK background and relationship to physical-chemical properties, QSPR directed med-chem experience (quantitative structure properties relationships), IND eCTD submissions, project management, portfolio management, extensive experience with global contract manufacturing and research organization management
Microbion Corporation
View-
Chief Scientific OfficerMicrobion Corporation Apr 2018 - PresentBozeman, Montana, Us -
Chief Operating OfficerEnsysce Biosciences 2017 - PresentLa Jolla, California, Us -
Chief Scientific OfficerNucleus Bioscience Oct 2017 - Present
-
Scientific AdvisorJournal Of Pharmaceutical Sciences Jul 2013 - PresentAdvise the editorial team about the scope and direction of JPharmSci, review manuscripts, and be an advocate for the Journal by recruiting and submitting manuscripts from peers and in-house research.
-
Editoral Advisory Board MemberContract Pharma 2008 - Present•Advise the journal’s Editorial Team on opinions of scope and direction for the journal•Review contributed manuscripts and act as a technical expert for Q&As and editorials
-
Research Assistant ProfessorUniversity Of Arizona Nov 2002 - PresentTucson, Arizona, UsI maintain a Research Assistant Professor appointment in the Department of Pharmacy Practice and Science at the UofA. -
OwnerPharmolecular, Llc Feb 2000 - PresentDrug development contract consulting services related to all phases of drug development. Specializing in program management, ADME-PK/TK, and CMC strategy and development. Also experienced in QSAR and QSPR (quantitative activity/structure activities/properties relationships) to help translate medicinal chemistry efforts into deliverable drugs by modeling physicochemical properties, de novo, from structures.
-
Vice President, Chemistry, Manufacturing, And ControlsCascadian Therapeutics, Inc. Jan 2015 - Mar 2018Seattle, Washington, UsResponsible for internal and contract CMC activities and regulatory strategies for APIs and formulations from discovery through commercial launch including lifecycle management and IP planning. I chose to leave this role after the acquisition of Cascadian Therapeutics by Seattle Genetics. -
Sr Director, Pharmaceutical DevelopmentOncothyreon, Inc. Nov 2008 - Dec 2014Us -
Director, Pharmaceutical DevelopmentBiomira Inc. Oct 2006 - Oct 2008CaResponsible for chemistry, manufacturing, and controls (CMC) of both active pharmaceutical ingredients and drug products for the company's small molecule and vaccine pipeline. -
Senior ScientistProlx Pharmaceuticals Corp. 2002 - 2006• Pre-clinical drug development for vaccine and small molecule oncology therapeutics• FDA liaison for pre-IND and IND submissions and meetings, authoring relevant sections of annual reports and amendments for existing INDs, updating Investigator Brochures and Protocols• Manage CROs and CCMOs projects and academic collaborations• Non-clinical toxicology program development, test article manufacture, testing, and release• Contribute to development, submission, and maintenance of SBIR grant applications and patents• Principal Investigator of SBIR and NCDDG core grants• Member of Portfolio Management Committee (in- and out-licensing and project prioritization)• Project management and development: pre-IND and IND project planning, management and FDA liaison; writing and support of CMC and PHARM/TOX IND sections; outsourcing contract acquisition, management, due diligence and auditing for GMP and GLP work• Pharmaceutical: pre-formulation, formulation of oral and parenteral dosage forms for pre-clinical and clinical use; sterile lyophilization; polymorph and crystallinity screens; salt form selection• Pharmaco/Toxicokinetics: PK/TK study design; pre-clinical and clinical analyses; CYP metabolism, inhibition, and induction screens; metabolic pathway elucidation• Chemistry: lead drug substance development from med-chem through clinical; process chemistry; internal and cGMP CMO management; crystallization and solid-state characterization • Analytical: metabolite separation and structure elucidation; bioanalytic and stability indicating assay development; assay validation; normal and reverse phase LC/MS; stereoselective LC separation; numerous equipment expertise• Facilities design, management, and supervision at multiple sites including relocations; IT lead for LAN and server setup; equipment installation and qualification including 21 Part 11 as needed
Jeff Millard Skills
Jeff Millard Education Details
-
University Of ArizonaPharmaceutics And Drug Design -
Rice UniversityBiochemistry/Biology & Philosophy/Religious Studies -
Bartlesville High School
Frequently Asked Questions about Jeff Millard
What company does Jeff Millard work for?
Jeff Millard works for Microbion Corporation
What is Jeff Millard's role at the current company?
Jeff Millard's current role is C-suite scientist with extensive CMC, business, and regulatory strategy experience..
What is Jeff Millard's email address?
Jeff Millard's email address is ny****@****hoo.com
What is Jeff Millard's direct phone number?
Jeff Millard's direct phone number is +120680*****
What schools did Jeff Millard attend?
Jeff Millard attended University Of Arizona, Rice University, Bartlesville High School.
What skills is Jeff Millard known for?
Jeff Millard has skills like Technology Transfer, Chemistry, Drug Development, Biotechnology, R&d, Analytical Chemistry, Formulation, Gmp, Pharmaceutical Industry, Medicinal Chemistry, Biopharmaceuticals, Cmc.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial